The FDA Approved A New Medication To Prevent A Common Hospital Infection

New Jersey-based CorMedix received the go-ahead for DefenCath, its treatment that helps prevent a common and sometimes deadly type of infection seen in dialysis patients.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Science /science Innovation /innovation Healthcare /healthcare technology alexknappblog premium Source Type: news